skip to Main Content

Winners of the Annual Community Service Awards Announced

BioForward, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster, is pleased to announce the winners of its 2022 and 2023 Community Service Awards. The awards recognize and showcase the hard work and efforts of Wisconsin’s biohealth industry organizations…

Read More

Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate

With these results, Breyanzi has now demonstrated clinically meaningful benefit across the broadest array of B-cell malignancies of any CD19-directed CAR T cell therapy, underscoring the company’s leadership in advancing innovative therapies for many types of hematological malignancies (PRINCETON, N.J.,…

Read More

Pall Life Sciences is now part of Cytiva!

We’re thrilled to share the news — Cytiva and the Life Sciences business of Pall have united under the Cytiva name! With a mission to advance therapeutics from discovery to delivery, combining our organizations just makes sense. Together, we bring…

Read More
Back To Top